8-K Announcements
6Material company update
May 6, 2026·SEC
Material company update
Apr 15, 2026·SEC
Material company update
Mar 13, 2026·SEC
U.S. Physical Therapy, Inc.(USPH)Earnings, Financials & Key Ratios
USPH•NYSE
$59.00
$897M mkt cap·41.5× P/E·Price updated May 7, 2026
AboutU.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.Show more
- Revenue$781M+16.3%
- EBITDA$103M+25.6%
- Net Income$15M-43.1%
- EPS (Diluted)1.42-22.8%
- Gross Margin20.15%+9.1%
- EBITDA Margin13.17%+7.9%
- Operating Margin10.3%+9.4%
- Net Margin1.93%-51.1%
- ROE1.97%-47.5%
- ROIC5.55%+3.7%
- Debt/Equity0.55+42.2%
- Interest Coverage9.23+8.4%
USPH Key Insights
U.S. Physical Therapy, Inc. (USPH) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 13.0%
- ✓Healthy dividend yield of 3.1%
- ✓Trading at only 1.2x book value
✗Weaknesses
- ✗Weak 3Y average ROE of 2.8%
- ✗Profits declining 13.2% over 5 years
- ✗Dividend payout exceeds 100% of earnings
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
USPH Price & Volume
U.S. Physical Therapy, Inc. (USPH) stock price & volume — 10-year historical chart
Loading chart...
USPH Growth Metrics
U.S. Physical Therapy, Inc. (USPH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years8.95%
5 Years13.05%
3 Years12.19%
TTM4.05%
Profit CAGR
10 Years-3.84%
5 Years-13.2%
3 Years-18.93%
TTM-64.54%
EPS CAGR
10 Years-2.18%
5 Years-19.07%
3 Years-24.81%
TTM-77.06%
Return on Capital
10 Years11.36%
5 Years8.07%
3 Years6.78%
Last Year7.6%
USPH Recent Earnings
U.S. Physical Therapy, Inc. (USPH) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (42%)●Beat Revenue 5/12 qtrs (42%)
Q2 2026Latest
May 6, 2026EPS
$0.46
Est $0.55
-16.4%
Revenue
$198M
Est $201M
-1.3%
Q1 2026
Feb 25, 2026EPS
$0.67
Est $0.67
+0.0%
Revenue
$203M
Est $200M
+1.4%
Q4 2025
Nov 5, 2025EPS
$0.66
Est $0.67
-1.5%
Revenue
$164M
Est $200M
-18.0%
Q3 2025
Aug 6, 2025EPS
$0.81
Est $0.71
+14.1%
Revenue
$164M
Est $190M
-13.5%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.46vs $0.55-16.4% | $198Mvs $201M-1.3% |
| Q1 2026 | Feb 25, 2026 | $0.67vs $0.67+0.0% | $203Mvs $200M+1.4% |
| Q4 2025 | Nov 5, 2025 | $0.66vs $0.67-1.5% | $164Mvs $200M-18.0% |
| Q3 2025 | Aug 6, 2025 | $0.81vs $0.71+14.1% | $164Mvs $190M-13.5% |
Based on last 12 quarters of dataView full earnings history →
USPH Peer Comparison
U.S. Physical Therapy, Inc. (USPH) competitors in Outpatient clinics and surgery centers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 AFCG | 72.7M | 3.09 | -3.25 | -39.65% | -333.95% | -11.13% | 0.43 | |
 CCRN | 423.05M | 13.09 | -4.47 | -21.56% | -12.96% | -27.1% | 0.01 | |
 NHC | 2.66B | 171.42 | 22.35 | 13.23% | 6.75% | 9.57% | 0.08 | |
 ENSG | 10.18B | 174.30 | 29.85 | 18.72% | 6.89% | 16.61% | 1.86 | |
 ACHC | 2.25B | 24.46 | -2.01 | 5.04% | -32.84% | -40.92% | 1.24 | |
 SEM | 2.04B | 16.44 | 13.93 | 5.12% | 2.42% | 6.57% | 1.82 | |
 SGRY | 1.87B | 14.31 | -23.46 | 6.24% | -2.28% | -2.15% | 1.14 | |
 OPCH | 3.25B | 20.75 | 16.34 | 13.03% | 3.64% | 15.28% |
Compare USPH vs Peers
U.S. Physical Therapy, Inc. (USPH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
USPH Income Statement
U.S. Physical Therapy, Inc. (USPH) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 414.05M | 453.91M | 481.97M | 422.97M | 495.02M | 553.14M | 604.8M | 671.35M | 780.99M | 695.26M |
| Revenue Growth % | 16.13% | 9.63% | 6.18% | -12.24% | 17.04% | 11.74% | 9.34% | 11% | 16.33% | 4.05% |
| Cost of Goods Sold | 323.43M | 352.25M | 369.5M | 328.52M | 377.84M | 441.12M | 483.29M | 547.42M | 623.65M | 542.15M |
| COGS % of Revenue | 78.11% | 77.6% | 76.66% | 77.67% | 76.33% | 79.75% | 79.91% | 81.54% | 79.85% | - |
| Gross Profit | 90.62M▲ 0% | 101.66M▲ 12.2% | 112.47M▲ 10.6% | 94.45M▼ 16.0% | 117.18M▲ 24.1% | 112.02M▼ 4.4% | 121.51M▲ 8.5% | 123.92M▲ 2.0% | 157.34M▲ 27.0% | 153.11M▲ 0% |
| Gross Margin % | 21.89% | 22.4% | 23.34% | 22.33% | 23.67% | 20.25% | 20.09% | 18.46% | 20.15% | 22.02% |
| Gross Profit Growth % | 10.49% | 12.19% | 10.63% | -16.02% | 24.07% | -4.4% | 8.47% | 1.98% | 26.97% | - |
| Operating Expenses | 35.89M | 41.35M | 45.05M | 42.04M | 46.53M | 55.22M | 69.45M | 60.71M | 76.91M | 68.36M |
| OpEx % of Revenue | 8.67% | 9.11% | 9.35% | 9.94% | 9.4% | 9.98% | 11.48% | 9.04% | 9.85% | - |
| Selling, General & Admin | 35.89M | 41.35M | 45.05M | 42.04M | 46.53M | 46.11M | 0 | 58.29M | 0 | 17.48M |
| SG&A % of Revenue | 8.67% | 9.11% | 9.35% | 9.94% | 9.4% | 8.34% | - | 8.68% | - | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 9.11M | 69.45M | 2.42M | 76.91M | 2.21M |
| Operating Income | 54.73M▲ 0% | 60.31M▲ 10.2% | 67.42M▲ 11.8% | 52.41M▼ 22.3% | 70.65M▲ 34.8% | 56.8M▼ 19.6% | 52.06M▼ 8.3% | 63.21M▲ 21.4% | 80.43M▲ 27.2% | 84.76M▲ 0% |
| Operating Margin % | 13.22% | 13.29% | 13.99% | 12.39% | 14.27% | 10.27% | 8.61% | 9.42% | 10.3% | 12.19% |
| Operating Income Growth % | 10.49% | 10.21% | 11.79% | -22.26% | 34.79% | -19.6% | -8.34% | 21.42% | 27.24% | - |
| EBITDA | 64.44M | 70.07M | 77.52M | 62.95M | 82.24M | 71.54M | 67.76M | 81.89M | 102.82M | 106.94M |
| EBITDA Margin % | 15.56% | 15.44% | 16.08% | 14.88% | 16.61% | 12.93% | 11.2% | 12.2% | 13.17% | 15.38% |
| EBITDA Growth % | 10.51% | 8.74% | 10.63% | -18.8% | 30.65% | -13.01% | -5.29% | 20.87% | 25.56% | 25.89% |
| D&A (Non-Cash Add-back) | 9.71M | 9.76M | 10.1M | 10.53M | 11.59M | 14.74M | 15.7M | 18.68M | 22.39M | 22.18M |
| EBIT | 54.82M | 62.25M | 72.98M | 67.15M | 74.14M | 61.35M | 58.68M | 68.22M | 87.27M | 67.67M |
| Net Interest Income | -20.97M | -1.95M | -2.03M | -1.49M | -942K | -5.78M | -5.53M | -4.07M | -9.35M | -7.1M |
| Interest Income | 88K | 93K | 46K | 142K | 0 | 0 | 3.77M | 3.94M | 105K | 97K |
| Interest Expense | 21.06M | 2.04M | 2.08M | 1.63M | 942K | 5.78M | 9.3M | 8.02M | 9.46M | 4.39M |
| Other Income/Expense | -20.97M | -103K | 3.48M | 13.1M | 2.55M | -1.23M | -2.69M | -3M | -2.62M | -13.71M |
| Pretax Income | 33.76M▲ 0% | 60.21M▲ 78.4% | 70.91M▲ 17.8% | 65.51M▼ 7.6% | 73.2M▲ 11.7% | 55.57M▼ 24.1% | 49.38M▼ 11.1% | 60.21M▲ 21.9% | 77.81M▲ 29.2% | 71.05M▲ 0% |
| Pretax Margin % | 8.15% | 13.26% | 14.71% | 15.49% | 14.79% | 10.05% | 8.16% | 8.97% | 9.96% | 10.22% |
| Income Tax | 6.03M | 11.37M | 13.65M | 13.02M | 15.27M | 12.16M | 12.16M | 14.61M | 19.81M | 18.36M |
| Effective Tax Rate % | 17.87% | 18.88% | 19.25% | 19.88% | 20.86% | 21.89% | 24.62% | 24.26% | 25.46% | 25.83% |
| Net Income | 22.26M▲ 0% | 10.1M▼ 54.6% | 28.15M▲ 178.6% | 30.56M▲ 8.6% | 27.82M▼ 9.0% | 28.27M▲ 1.6% | 14.67M▼ 48.1% | 26.46M▲ 80.3% | 15.06M▼ 43.1% | 10.55M▲ 0% |
| Net Margin % | 5.38% | 2.23% | 5.84% | 7.23% | 5.62% | 5.11% | 2.43% | 3.94% | 1.93% | 1.52% |
| Net Income Growth % | 8.3% | -54.61% | 178.59% | 8.58% | -8.97% | 1.61% | -48.09% | 80.32% | -43.08% | -64.54% |
| Net Income (Continuing) | 27.72M | 48.84M | 57.26M | 52.49M | 57.92M | 43.41M | 37.22M | 45.6M | 58.01M | 49.58M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 104.1M | 134.87M | 139.19M | 133.81M | 156.84M | 168.78M | 176.04M | 270.12M | 293.31M | 313.9M |
| EPS (Diluted) | 1.76▲ 0% | 0.80▼ 54.5% | 4.49▲ 461.3% | 4.09▼ 8.9% | 4.49▲ 9.8% | 3.34▼ 25.6% | 1.28▼ 61.7% | 1.84▲ 43.8% | 1.42▼ 22.8% | 0.70▲ 0% |
| EPS Growth % | 7.32% | -54.55% | 461.25% | -8.91% | 9.78% | -25.61% | -61.68% | 43.75% | -22.83% | -77.06% |
| EPS (Basic) | 1.76 | 0.80 | 4.49 | 4.09 | 4.49 | 3.34 | 1.28 | 1.84 | 1.42 | - |
| Diluted Shares Outstanding | 12.57M | 12.67M | 12.76M | 12.84M | 12.9M | 12.98M | 14.19M | 15.06M | 15.18M | 15.17M |
| Basic Shares Outstanding | 12.57M | 12.67M | 12.76M | 12.84M | 12.9M | 12.98M | 14.19M | 15.06M | 15.18M | 15.17M |
| Dividend Payout Ratio | 45.23% | 115.45% | 51.71% | 13.45% | 67.45% | 75.42% | 164.43% | 100.3% | 181.66% | - |
USPH Balance Sheet
U.S. Physical Therapy, Inc. (USPH) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 77.08M | 79.21M | 85.39M | 87.64M | 95.17M | 111.27M | 233.38M | 137.58M | 139.99M | 139.11M |
| Cash & Short-Term Investments | 21.93M | 23.37M | 23.55M | 32.92M | 28.57M | 31.59M | 152.82M | 41.36M | 35.57M | 28.44M |
| Cash Only | 21.93M | 23.37M | 23.55M | 32.92M | 28.57M | 31.59M | 152.82M | 41.36M | 35.57M | 28.44M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 50.36M | 51.49M | 56.05M | 50.95M | 62.42M | 68.61M | 51.87M | 85.67M | 64.25M | 96.72M |
| Days Sales Outstanding | 44.4 | 41.41 | 42.45 | 43.96 | 46.02 | 45.27 | 31.3 | 46.58 | 30.03 | 45.37 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 10.44M | 11.1M | 5.79M | 3.77M | 4.18M | 11.07M | 28.68M | 10.55M | 40.17M | 13.95M |
| Total Non-Current Assets | 341.9M | 363.95M | 475.46M | 506.73M | 654.26M | 746.89M | 763.86M | 1.03B | 1.06B | 1.1B |
| Property, Plant & Equipment | 20.39M | 20.17M | 103.68M | 103.26M | 119.41M | 127.75M | 129.53M | 166.08M | 271.07M | 187.82M |
| Fixed Asset Turnover | 20.31x | 22.51x | 4.65x | 4.10x | 4.15x | 4.33x | 4.67x | 4.04x | 2.88x | 3.47x |
| Goodwill | 271.34M | 293.52M | 317.68M | 345.65M | 434.68M | 494.1M | 509.57M | 667.15M | 692.39M | 715.87M |
| Intangible Assets | 48.95M | 48.83M | 52.59M | 56.28M | 86.38M | 108.75M | 109.68M | 179.31M | 172.86M | 179.82M |
| Long-Term Investments | -2.06M | -2.48M | 0 | 0 | 12.21M | 12.13M | 12.26M | 12.19M | 12.28M | 49.33M |
| Other Non-Current Assets | 1.22M | 1.43M | 1.52M | 1.54M | 1.58M | 4.15M | 2.82M | 5.16M | -84.58M | -68.88M |
| Total Assets | 418.98M▲ 0% | 443.17M▲ 5.8% | 560.85M▲ 26.6% | 594.36M▲ 6.0% | 749.43M▲ 26.1% | 858.15M▲ 14.5% | 997.24M▲ 16.2% | 1.17B▲ 17.1% | 1.2B▲ 3.1% | 1.24B▲ 0% |
| Asset Turnover | 0.99x | 1.02x | 0.86x | 0.71x | 0.66x | 0.64x | 0.61x | 0.58x | 0.65x | 0.58x |
| Asset Growth % | 19.29% | 5.77% | 26.55% | 5.98% | 26.09% | 14.51% | 16.21% | 17.07% | 3.13% | 39.94% |
| Total Current Liabilities | 39.55M | 41.95M | 60.56M | 93.49M | 83.48M | 85.49M | 102.19M | 116.28M | 139.04M | 117.3M |
| Accounts Payable | 2.17M | 2.02M | 2.49M | 1.33M | 6.47M | 6.5M | 3.9M | 5.94M | 6.06M | 6.76M |
| Days Payables Outstanding | 2.44 | 2.09 | 2.46 | 1.48 | 6.25 | 5.38 | 2.94 | 3.96 | 3.55 | 4.11 |
| Short-Term Debt | 4.04M | 1.43M | 728K | 4.9M | 830K | 7.86M | 7.69M | 11M | 52M | 53.58M |
| Deferred Revenue (Current) | 2.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 9.52M | 16.77M | 0 | 0 | 0 | 0 | 22.49M | 0 | 80.98M | 56.96M |
| Current Ratio | 1.95x | 1.89x | 1.41x | 0.94x | 1.14x | 1.30x | 2.28x | 1.18x | 1.01x | 1.01x |
| Quick Ratio | 1.95x | 1.89x | 1.41x | 0.94x | 1.14x | 1.30x | 2.28x | 1.18x | 1.01x | 1.01x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | 41.25 |
| Total Non-Current Liabilities | 70.46M | 50.4M | 120.83M | 90.9M | 213.5M | 288.1M | 242.81M | 292.14M | 294.77M | 341.89M |
| Long-Term Debt | 56.73M | 38.4M | 50.36M | 16.6M | 117.59M | 175.83M | 138.99M | 142.53M | 263.17M | 194.04M |
| Capital Lease Obligations | 0 | 0 | 60.26M | 61.98M | 74.19M | 77.93M | 76.65M | 101.87M | 110.57M | 436.24M |
| Deferred Tax Liabilities | 10.88M | 9.01M | 10.07M | 7.78M | 14.38M | 21.3M | 24.82M | 29.46M | 28.39M | 129.26M |
| Other Non-Current Liabilities | 13.73M | 12M | 141K | 4.54M | 7.34M | 13.03M | 2.36M | 18.27M | -107.36M | -95.51M |
| Total Liabilities | 110.01M | 92.35M | 181.39M | 184.39M | 296.98M | 373.59M | 345M | 408.42M | 433.81M | 459.19M |
| Total Debt | 60.77M | 39.84M | 137.83M | 110.99M | 223.08M | 295.34M | 258.59M | 295.23M | 425.74M | 362.83M |
| Net Debt | 38.84M | 16.47M | 114.28M | 78.07M | 194.51M | 263.74M | 105.76M | 253.87M | 390.17M | 334.39M |
| Debt / Equity | 0.20x | 0.11x | 0.36x | 0.27x | 0.49x | 0.61x | 0.40x | 0.39x | 0.55x | 0.55x |
| Debt / EBITDA | 0.94x | 0.57x | 1.78x | 1.76x | 2.71x | 4.13x | 3.82x | 3.61x | 4.14x | 3.39x |
| Net Debt / EBITDA | 0.60x | 0.24x | 1.47x | 1.24x | 2.37x | 3.69x | 1.56x | 3.10x | 3.79x | 3.79x |
| Interest Coverage | 2.60x | 30.49x | 35.11x | 41.09x | 78.70x | 10.62x | 6.31x | 8.51x | 9.23x | 15.42x |
| Total Equity | 308.97M▲ 0% | 350.82M▲ 13.5% | 379.45M▲ 8.2% | 409.97M▲ 8.0% | 452.44M▲ 10.4% | 484.57M▲ 7.1% | 652.24M▲ 34.6% | 759.05M▲ 16.4% | 769.74M▲ 1.4% | 782.87M▲ 0% |
| Equity Growth % | 19.81% | 13.54% | 8.16% | 8.04% | 10.36% | 7.1% | 34.6% | 16.38% | 1.41% | 35.48% |
| Book Value per Share | 24.58 | 27.70 | 29.75 | 31.94 | 35.08 | 37.32 | 45.97 | 50.39 | 50.72 | 51.62 |
| Total Shareholders' Equity | 204.87M | 215.94M | 240.26M | 276.16M | 295.61M | 315.79M | 476.19M | 488.93M | 476.43M | 468.98M |
| Common Stock | 148K | 149K | 150K | 151K | 151K | 152K | 172K | 172K | 174K | 175K |
| Retained Earnings | 162.41M | 167.4M | 184.35M | 212.01M | 224.4M | 232.95M | 223.77M | 227.26M | 227.22M | 216.88M |
| Treasury Stock | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -31.63M | -37.19M | -37.19M |
| Accumulated OCI | -60.48M | -64.15M | 0 | 0 | 0 | 4M | 2.78M | 2.8M | 714K | 978K |
| Minority Interest | 104.1M | 134.87M | 139.19M | 133.81M | 156.84M | 168.78M | 176.04M | 270.12M | 293.31M | 313.9M |
USPH Cash Flow Statement
U.S. Physical Therapy, Inc. (USPH) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 56.53M | 73M | 62.45M | 100M | 76.41M | 58.54M | 81.98M | 74.94M | 75.06M | 75.06M |
| Operating CF Margin % | 13.65% | 16.08% | 12.96% | 23.64% | 15.43% | 10.58% | 13.55% | 11.16% | 9.61% | - |
| Operating CF Growth % | 10.73% | 29.15% | -14.46% | 60.13% | -23.59% | -23.39% | 40.04% | -8.59% | 0.16% | 219.62% |
| Net Income | 27.72M | 48.84M | 57.26M | 52.49M | 57.92M | 43.41M | 37.22M | 45.6M | 58.01M | 10.55M |
| Depreciation & Amortization | 9.71M | 9.76M | 10.1M | 10.53M | 11.59M | 14.74M | 15.7M | 18.68M | 22.39M | 22.52M |
| Stock-Based Compensation | 5.03M | 5.94M | 6.99M | 7.92M | 7.87M | 7.26M | 7.24M | 7.82M | 8.27M | 8.81M |
| Deferred Taxes | -4.55M | 4.81M | 4.65M | -258K | 5.69M | 4.31M | 4.49M | 5.37M | 11.41M | 9.45M |
| Other Non-Cash Items | 4.29M | 2.92M | -560K | 5.67M | 5.12M | 10.24M | 22.27M | 9.88M | 2.18M | -4.35M |
| Working Capital Changes | 14.32M | 732K | -15.98M | 23.64M | -11.78M | -21.43M | -4.93M | -12.4M | -27.19M | 1.1M |
| Change in Receivables | -3.45M | -3.43M | -6.38M | 2.56M | -10.96M | -10.28M | -6M | -11.89M | -9.06M | -8.38M |
| Change in Inventory | -794K | -742K | 4.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 6.98M | 4.88M | -4.21M | 0 | 0 | -7.75M | 15K | 0 | -7.8M | -2.57M |
| Cash from Investing | -43.58M | -23.91M | -37.99M | -51.2M | -124.14M | -81.27M | -45.02M | -149.45M | -36.71M | -69.89M |
| Capital Expenditures | -7.09M | -7.19M | -10.19M | -7.64M | -8.2M | -8.25M | -9.29M | -9.19M | -14.07M | -16.86M |
| CapEx % of Revenue | 1.71% | 1.58% | 2.11% | 1.81% | 1.66% | 1.49% | 1.54% | 1.37% | 1.8% | - |
| Acquisitions | -36.56M | -16.37M | -27.87M | -43.56M | -116.09M | -74.28M | -36.87M | -142.04M | 0 | -8.39M |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 81K | -349K | 64K | 0 | 152K | 1.26M | 1.15M | 1.77M | -22.64M | -44.63M |
| Cash from Financing | -11.06M | -47.66M | -24.27M | -39.42M | 43.38M | 25.76M | 84.27M | -36.95M | -44.14M | -24.4M |
| Debt Issued (Net) | 6.77M | -20.04M | 6.57M | -31.04M | 93.1M | 64.19M | -39.15M | 4.3M | 8.06M | -4.72M |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 163.65M | 0 | -5.57M | -5.57M |
| Dividends Paid | -10.07M | -11.66M | -14.55M | -4.11M | -18.77M | -21.32M | -24.13M | -26.54M | -27.36M | -34.37M |
| Share Repurchases | 0 | 0 | 502K | 0 | 0 | 0 | 0 | 0 | -5.57M | -5.57M |
| Other Financing | -7.77M | -15.95M | -16.29M | -4.28M | -30.96M | -17.11M | -16.1M | -14.71M | -19.27M | 20.25M |
| Net Change in Cash | 1.89M▲ 0% | 1.44M▼ 23.9% | 180K▼ 87.5% | 9.37M▲ 5105.6% | -4.35M▼ 146.4% | 3.03M▲ 169.6% | 121.23M▲ 3905.0% | -111.46M▼ 191.9% | -5.79M▲ 94.8% | -10.74M▲ 0% |
| Free Cash Flow | 49.43M▲ 0% | 65.81M▲ 33.1% | 52.26M▼ 20.6% | 92.36M▲ 76.7% | 68.2M▼ 26.1% | 50.29M▼ 26.3% | 72.68M▲ 44.5% | 65.75M▼ 9.5% | 60.99M▼ 7.2% | 66.68M▲ 0% |
| FCF Margin % | 11.94% | 14.5% | 10.84% | 21.84% | 13.78% | 9.09% | 12.02% | 9.79% | 7.81% | 9.59% |
| FCF Growth % | 15.52% | 33.14% | -20.59% | 76.73% | -26.15% | -26.27% | 44.53% | -9.53% | -7.25% | 18.89% |
| FCF per Share | 3.93 | 5.20 | 4.10 | 7.20 | 5.29 | 3.87 | 5.12 | 4.36 | 4.02 | 4.02 |
| FCF Conversion (FCF/Net Income) | 2.54x | 7.23x | 2.22x | 3.27x | 2.75x | 2.07x | 5.59x | 2.83x | 4.98x | 6.32x |
| Interest Paid | 2.11M | 2.36M | 1.89M | 1.2M | 1.35M | 5.69M | 8.65M | 7.21M | 0 | 5.1M |
| Taxes Paid | 8.54M | 9.18M | 9.86M | 7.68M | 12.21M | 7.62M | 4.93M | 4.83M | 0 | 4.45M |
USPH Key Ratios
U.S. Physical Therapy, Inc. (USPH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 7.85% | 3.06% | 7.71% | 7.74% | 6.45% | 6.03% | 2.58% | 3.75% | 1.97% | 1.36% |
| Return on Invested Capital (ROIC) | 12.88% | 12.65% | 11.75% | 8.01% | 9.34% | 6.11% | 5.18% | 5.35% | 5.55% | 5.55% |
| Gross Margin | 21.89% | 22.4% | 23.34% | 22.33% | 23.67% | 20.25% | 20.09% | 18.46% | 20.15% | 22.02% |
| Net Margin | 5.38% | 2.23% | 5.84% | 7.23% | 5.62% | 5.11% | 2.43% | 3.94% | 1.93% | 1.52% |
| Debt / Equity | 0.20x | 0.11x | 0.36x | 0.27x | 0.49x | 0.61x | 0.40x | 0.39x | 0.55x | 0.55x |
| Interest Coverage | 2.60x | 30.49x | 35.11x | 41.09x | 78.70x | 10.62x | 6.31x | 8.51x | 9.23x | 15.42x |
| FCF Conversion | 2.54x | 7.23x | 2.22x | 3.27x | 2.75x | 2.07x | 5.59x | 2.83x | 4.98x | 6.32x |
| Revenue Growth | 16.13% | 9.63% | 6.18% | -12.24% | 17.04% | 11.74% | 9.34% | 11% | 16.33% | 4.05% |
USPH SEC Filings & Documents
U.S. Physical Therapy, Inc. (USPH) SEC filings — annual & quarterly reports (10-K, 10-Q)
USPH Frequently Asked Questions
U.S. Physical Therapy, Inc. (USPH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
U.S. Physical Therapy, Inc. (USPH) reported $695.3M in revenue for fiscal year 2025. This represents a 2059% increase from $32.2M in 1996.
U.S. Physical Therapy, Inc. (USPH) grew revenue by 16.3% over the past year. This is strong growth.
Yes, U.S. Physical Therapy, Inc. (USPH) is profitable, generating $10.5M in net income for fiscal year 2025 (1.9% net margin).
Dividend & Returns
Yes, U.S. Physical Therapy, Inc. (USPH) pays a dividend with a yield of 3.06%. This makes it attractive for income-focused investors.
U.S. Physical Therapy, Inc. (USPH) has a return on equity (ROE) of 2.0%. This is below average, suggesting room for improvement.
U.S. Physical Therapy, Inc. (USPH) generated $66.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More USPH
U.S. Physical Therapy, Inc. (USPH) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates